Abstract
The temporal characteristics of brain maturation could potentially represent a mediating effect between pubertal development and life outcomes. Using a large longitudinal dataset of children aged 9-12 from the Adolescent Brain Cognitive Development (ABCD) study we tested the associations between pubertal status and brain maturation. Brain maturation was assessed using brain age prediction with a deep learning approach based on convolutional neural networks and minimally processed T1-weighted structural MRI data. Brain age prediction provided highly accurate and reliable estimates of individual age, with an overall mean absolute error of 0.7 and 1.4 years at the two timepoints respectively, and an intraclass correlation of 0.65. Linear mixed effects (LME) models accounting for age and sex showed that on average, advancing pubertal development by one pubertal stage was associated with a 2.4 months higher brain age across time points (β= 0.10, p<.001). Further, significant interactions with time demonstrated that higher rates of pubertal development were associated with larger positive changes in brain age over time (p<.001). These results demonstrate a link between sexual development and brain maturation in early adolescence, and provides a basis for further investigations of the complex sociobiological impacts of puberty on the adolescent brain and mind.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
The work was performed on the Service for Sensitive Data (TSD) platform, owned by the University of Oslo, operated and developed by the TSD service group at the University of Oslo IT-Department (USIT). Computations were also performed using resources provided by UNINETT Sigma2: the National Infrastructure for High Performance Computing and Data Storage in Norway. While working on this study, the authors received funding from the Research Council of Norway (273345, 249795, 298646, 300768, 223273), the South-Eastern Norway Regional Health Authority (2018076, 2019101), the European Research Council under the European Union's Horizon 2020 research and innovation program (802998), and the Swiss National Science Foundation (PZ00P3_193658).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The current study has been approved by the Regional Committees for Medical and Health Research Ethics South-East Norway
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
All data produced are available online at https://data-archive.nimh.nih.gov/abcd).